Clinical Trial

Intra-Arterial Magnesium Therapy After Mechanical Thrombectomy in Acute Ischemic Stroke

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated May 14, 2025 (before its estimated June 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of this Phase I unblinded, dose-escalation trial is to evaluate the safety and tolerability of intra-arterial magnesium sulfate injection after mechanical thrombectomy in patients experiencing acute ischemic stroke. This trial is one of the first trials to look at IA administration of magnesium sulfate into at risk brain tissue in a selective and localized fashion.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-05-01.
Trial Details
NCT Number NCT06956521
Lead Sponsor Baylor College of Medicine
Conditions Acute Ischemic Stroke
Enrollment 30 participants
Start Date 2025-06
Primary Completion 2026-06 (estimated)
Study Completion 2026-07 (estimated)
Updated on ClinicalTrials.gov 2025-05-14